M&A: STRYKER CORP

Form Type: 8-K

Filing Date: 2025-01-07

Corporate Action: Acquisition

Type: New

Accession Number: 000119312525002537

Comments: On January 6, 2025, Stryker Corporation entered into a Merger Agreement with Inari Medical, Inc. Stryker will initiate a tender offer to purchase all outstanding shares of Inari at a price of $80.00 per share. The acquisition is subject to customary conditions including a minimum tender condition, regulatory approvals, and absence of legal restraints. The tender offer will remain open for at least 20 business days with provisions for extensions. Following the tender offer, the intention is for Stryker to merge with Inari, making Inari a wholly owned subsidiary of Stryker. The agreement includes customary representations, warranties, and a $163 million termination fee under certain conditions, with both companies agreeing to collaborate in efforts to complete the transaction. The document also mentions the risks associated with the acquisition process, including regulatory approvals and market conditions, along with a cautionary statement regarding forward-looking statements.

Document Link: View Document

Additional details:

Agreement Date: 2025-01-06


Target Company: Inari Medical, Inc.


Offer Price: 80.00


Minimum Tender Condition: at least a majority of Shares


Termination Fee: 163 million


End Date: 2025-07-07